Table I.
BZW2 expression level | |||||
---|---|---|---|---|---|
Clinicopatho-logical parameters | No. of cases | Negative | Positive | χ2 | P-value |
Sex | 1.602 | 0.206 | |||
Male | 29 | 19 | 10 | ||
Female | 21 | 10 | 11 | ||
Age (years) | 0.512 | 0.474 | |||
<18 | 28 | 15 | 13 | ||
≥18 | 22 | 14 | 8 | ||
Location | 1.667 | 0.434 | |||
Femur | 24 | 12 | 12 | ||
Tibia | 14 | 10 | 4 | ||
Elsewhere | 12 | 7 | 5 | ||
Tumor necrosis rate (%) | 0.006 | 0.939 | |||
<90 | 36 | 21 | 15 | ||
≥90 | 14 | 8 | 6 | ||
Cortical destruction | 0.487 | 0.485 | |||
Yes | 38 | 21 | 17 | ||
No | 12 | 8 | 4 | ||
Recurrence | 6.226 | 0.013a | |||
Yes | 23 | 9 | 14 | ||
No | 27 | 20 | 7 | ||
Metastasis | 0.112 | 0.738 | |||
Yes | 32 | 18 | 14 | ||
No | 18 | 11 | 7 | ||
Ennecking stage | 6.912 | 0.009a | |||
II | 34 | 24 | 10 | ||
III | 16 | 5 | 11 |
P<0.05. BZW2, basic leucine zipper and W2 domains 2.